Use in pregnancy: Reproduction studies conducted in pregnant rat showed a nonsignificant increase in the incidence of minor skeletal abnormalities in rats.
There is no evidence from laboratory investigations that galantamine may harm either pregnant women or unborn babies. Nevertheless, in case of pregnancy or possible pregnancy, it should be discussed with a physician whether it is advisable to use Reminyl.
Use in lactation: It is not known whether galantamine passes into human milk. Therefore, women on Reminyl should not breastfeed.